Bullboard Post History

by Claridge

Order by:

V.TLT	GBM indication: TLD-1433 vs Keytruda Here's what Bungee has been missing 3 days ago when he posted about his... June 2, 2019
V.TLT	RE:RE:RE:RE:RE:You are amazing Claridge Hempdoc ... Thanks for posting the Neuro-Oncology Advances journal paper... June 2, 2019
V.TLT	RE:RE:You are amazing Claridge Shav3 ... We all agree that TLT is a gem, given all we know now. As for... June 1, 2019
V.TLT	Top 10 immuno-oncology deals - 2018 and 2019 BDM ... March 2019 - Top 10 Immuno-Oncology Collaborations March 2018 ... June 1, 2019
V.TLT	RE:You are amazing Claridge UHN would benefit of the worldwide recognition of having been the university... June 1, 2019
V.TLT	RE:Why Is UHN It's common practice for academic institutions and professors to spin-off... June 1, 2019
V.TLT	RE:Mr. Lade, CEO - Devices division comes from a UHN spin-off Being aware now of the background of Mr. Lade, it's legitimate to think... June 1, 2019
V.TLT	Mr. Lade, CEO - Devices division comes from a UHN spin-off Prior to his nomination as TLT's CEO - Devices division, Kipton Lade... June 1, 2019
V.TLT	3 additional canadian institutional clinical oncology sites Regarding this: The Company is currently working with 3 additional... June 1, 2019
V.TLT	Analysts coverage around the corner We're getting closer and closer to analysts coverage Normal part... June 1, 2019
V.TLT	Who We Are - Oncology Center of Excellence Who We Are - Oncology Center of Excellence Share ... May 31, 2019
V.TLT	FDA Oncology Center of Excellence Real-Time Oncology Review For sure, our GBM and NSCLC indications could qaulify for this new program... May 31, 2019
V.TLT	RE:June will bring lots of interesting advances/visibility Add the AGM to my previous list ... May 31, 2019
V.TLT	June will bring lots of interesting advances/visibility - 3 presentations (1 with 9 papers) - 1 conference (CUA) - FDA conference... May 31, 2019
V.TLT	RE:RE:Laser Division Tidbit from News TLT's news releases are always a gem ... Arkady Mandel, MD, Ph.D., D.Sc... May 31, 2019
V.TLT	RE:Laser Division Tidbit from News Eoganacht ... The re-design of the TLC-2000 will integrate the ability to... May 31, 2019
V.TLT	RE:RE:RE:Speed it up Boys Bungee ... I'll report you for missing timing and for always whining on... May 31, 2019
V.TLT	RE:Speed it up Boys So amusing this Bungee ... Hurry up for what? Bungee forgot... May 31, 2019
V.TLT	RE:So far, there's no delays in the Ph. 2b That should reassure everybody ... and once again, our regular whiners lacked... May 31, 2019
V.TLT	Visibility at US BCAN level ... Seems like word is spreading ... 13 replies ... EnriqueSuave is helping... May 30, 2019

Become a member today, It's free!

Bullboard Post History

by Claridge

GBM indication: TLD-1433 vs Keytruda

RE:RE:RE:RE:RE:You are amazing Claridge

RE:RE:You are amazing Claridge

Top 10 immuno-oncology deals - 2018 and 2019

RE:You are amazing Claridge

RE:Why Is UHN

RE:Mr. Lade, CEO - Devices division comes from a UHN spin-off

Mr. Lade, CEO - Devices division comes from a UHN spin-off

3 additional canadian institutional clinical oncology sites

Analysts coverage around the corner

Who We Are - Oncology Center of Excellence

FDA Oncology Center of Excellence Real-Time Oncology Review

RE:June will bring lots of interesting advances/visibility

June will bring lots of interesting advances/visibility

RE:RE:Laser Division Tidbit from News

RE:Laser Division Tidbit from News

RE:RE:RE:Speed it up Boys

RE:Speed it up Boys

RE:So far, there's no delays in the Ph. 2b

Visibility at US BCAN level ...

Featured News Links

This Gambling Tech Stock Might be the Safest Bet you’ll make this Year

Cam Copper Mine: Discovery of Large Near Surface EM Conductor

LISTEN to the Jetstream #1 HELIUM appraisal well roar! Flow & Pressure Build-Up Tests Commence

Featured Company

Jackpot Digital Inc. V.JJ

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by Claridge

Featured News Links

Featured Company